Predictors of 5-Year Change in Plasma 25-hydroxyvitamin D (25(OH)D) Concentrations in Postmenopausal Women

Start Date

25-10-2012 11:00 AM

Description

Objective: Determine the predictors of 5-year change in (∆) 25(OH)D concentrations. Methods: Postmenopausal women in the Osteoporosis and Periodontal Disease Study (N=668) had 25(OH)D assessments at baseline (1997-2000) and 5-years (2002-2005). Baseline and ∆ dietary, lifestyle and health-related factors were tested as predictors using linear regression. Results: The mean increase in 25(OH)D was 7.7 nmol/L (SD=0.7, P<0.001). Predictors explained 31% of the variance in ∆ 25(OH)D and included baseline 25(OH)D, baseline and ∆ vitamin D supplement intake and physical activity, ∆ season of blood draw, ∆ body mass index, ∆ whole body T-score, and baseline hormone use. Baseline 25(OH)D and ∆ vitamin D supplement intake explained the most variance (25%) in 25(OH)D. In exploratory analyses, there was a borderline significant interaction between baseline 25(OH)D and ∆ vitamin D after adjustment for predictors of ∆ 25(OH)D (P=0.063). The greatest increase in 25(OH)D (M=22.9 nmol/L, SD=16.8) occurred in women in the lowest tertile of baseline 25(OH)D who increased supplement intake from baseline to follow-up (M=400.6 IU/d, SD=240.7). Conclusions: Baseline 25(OH)D and ∆ vitamin D supplement intake were most predictive of increasing 25(OH)D. Increasing 25(OH)D through supplementation depends on initial 25(OH)D

This document is currently not available here.

Share

COinS
 
Oct 25th, 11:00 AM

Predictors of 5-Year Change in Plasma 25-hydroxyvitamin D (25(OH)D) Concentrations in Postmenopausal Women

Objective: Determine the predictors of 5-year change in (∆) 25(OH)D concentrations. Methods: Postmenopausal women in the Osteoporosis and Periodontal Disease Study (N=668) had 25(OH)D assessments at baseline (1997-2000) and 5-years (2002-2005). Baseline and ∆ dietary, lifestyle and health-related factors were tested as predictors using linear regression. Results: The mean increase in 25(OH)D was 7.7 nmol/L (SD=0.7, P<0.001). Predictors explained 31% of the variance in ∆ 25(OH)D and included baseline 25(OH)D, baseline and ∆ vitamin D supplement intake and physical activity, ∆ season of blood draw, ∆ body mass index, ∆ whole body T-score, and baseline hormone use. Baseline 25(OH)D and ∆ vitamin D supplement intake explained the most variance (25%) in 25(OH)D. In exploratory analyses, there was a borderline significant interaction between baseline 25(OH)D and ∆ vitamin D after adjustment for predictors of ∆ 25(OH)D (P=0.063). The greatest increase in 25(OH)D (M=22.9 nmol/L, SD=16.8) occurred in women in the lowest tertile of baseline 25(OH)D who increased supplement intake from baseline to follow-up (M=400.6 IU/d, SD=240.7). Conclusions: Baseline 25(OH)D and ∆ vitamin D supplement intake were most predictive of increasing 25(OH)D. Increasing 25(OH)D through supplementation depends on initial 25(OH)D

Archival Statement

This material is part of a digital archival collection. This item was created or digitized prior to April 24, 2026, or is a reproduction of physical media created before that date. It is preserved specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II regulations, Butler Library provides accessible versions of archival materials upon request for affiliated faculty, staff, and students. To request an accommodation for this item, please submit a remediation request form.